Cereno, Scientific

Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD

Veröffentlicht: 19.03.2026 um 23:01 Uhr, prnewswire.co.uk

Cereno Scientific Sweden

View original content:https://www.prnewswire.co.uk/news-releases/cereno-scientific-receives-approval-to-initiate-fda-aligned-phase-i-pharmacokinetic-study-of-cs014-supporting-phase-ii-development-in-ph-ild-302715932.html

en | boerse | 68906589 |